Skip to content
Penetrating, critical, and timely scholarship on companies, industries, and economies
theAirnet.org
  • HOME
  • ABOUT
    • PURPOSE
    • PEOPLE
  • SCHOLARSHIP
    • AIR BOOKS
    • AIR REPORTS
  • PRESENTATIONS
  • DEBATE
    • AIR ANALYSIS
    • AIR IMPACT
  • INET-AIR COVID VACCINE PROJECT (CVP)
AIR ANALYSIS

Sick with “Shareholder Value”: US Pharma’s Financialized Business Model During the Pandemic

December 15, 2022December 15, 2022Oner Tulum

Click below to download the publication

Lazonick-Tulum_Sick with Shareholder Value – US Pharmas Financialized Business Model During the Pandemic_rev20221212

Share

Post navigation

Previous Post Investing in Innovation: Confronting Predatory Value Extraction in the U.S. Corporation
Facebook Twitter LinkedIn YouTube Rssfeed
© 2023 theAirnet.org
  • HOME
  • ABOUT
    • PURPOSE
    • PEOPLE
  • SCHOLARSHIP
    • AIR BOOKS
    • AIR REPORTS
  • PRESENTATIONS
  • DEBATE
    • AIR ANALYSIS
    • AIR IMPACT
  • INET-AIR COVID VACCINE PROJECT (CVP)

SUBSCRIBE / CONTACT US